Reuters logo
BRIEF-Five Prime Therapeutics presents preclinical research data on csf-1r and pd-1 blockade
April 3, 2017 / 12:15 PM / in 7 months

BRIEF-Five Prime Therapeutics presents preclinical research data on csf-1r and pd-1 blockade

April 3 (Reuters) - Five Prime Therapeutics Inc:

* Five Prime Therapeutics Inc says presents preclinical research data on csf-1r and pd-1 blockade

* Five Prime -results show that, when added to pd-1/pd-l1 blockade, surrogate antibody for fpa008 can significantly enhance anti-tumor efficacy Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below